Cover image of show Will Medicare Cover Ozempic in 2026?

Will Medicare Cover Ozempic in 2026?

Podcast by Inception Point AI

English

Technology & science

Limited Offer

2 months for 19 kr.

Then 99 kr. / monthCancel anytime.

  • 20 hours of audiobooks / month
  • Podcasts only on Podimo
  • All free podcasts
Get Started

About Will Medicare Cover Ozempic in 2026?

Medicare's new GLP-1 Bridge Program launches July 2026 with a $50 monthly copay, but Ozempic isn't covered for weight loss—only Foundayo, Wegovy, and Zepbound qualify. Pennie Power cuts through the confusion around eligibility requirements, BMI thresholds, and what beneficiaries must do during 2026 open enrollment. For more content like this, visit QuietPlease.ai This content was created in partnership and with the help of Artificial Intelligence AI.

All episodes

4 episodes

episode Will Medicare Cover Ozempic in 2026? - Do You Qualify? Decoding the BMI and Medical Criteria artwork

Will Medicare Cover Ozempic in 2026? - Do You Qualify? Decoding the BMI and Medical Criteria

Pennie Power breaks down Medicare's GLP-1 Bridge Program launching July 2026, explaining BMI thresholds, qualifying conditions, and prior authorization requirements for accessing Wegovy, Zepbound, and Foundayo at $50 monthly. Learn critical eligibility rules, including when measurements are taken and which plan types qualify for coverage. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7 Apr 2026 - 23 min
episode Will Medicare Cover Ozempic in 2026? - The $50 Copay: What's Actually Covered artwork

Will Medicare Cover Ozempic in 2026? - The $50 Copay: What's Actually Covered

Host Pennie Power breaks down Medicare's 2026 GLP-1 Bridge Program, revealing the critical detail catching people off-guard: Ozempic isn't covered for weight loss. Learn which three medications qualify for the $50 monthly copay (Foundayo, Wegovy, Zepbound), why that copay doesn't count toward deductibles, and how to navigate eligibility requirements before July 2026 to avoid costly surprises. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7 Apr 2026 - 24 min
Sign up to listen
En fantastisk app med et enormt stort udvalg af spændende podcasts. Podimo formår virkelig at lave godt indhold, der takler de lidt mere svære emner. At der så også er lydbøger oveni til en billig pris, gør at det er blevet min favorit app.
En fantastisk app med et enormt stort udvalg af spændende podcasts. Podimo formår virkelig at lave godt indhold, der takler de lidt mere svære emner. At der så også er lydbøger oveni til en billig pris, gør at det er blevet min favorit app.
Rigtig god tjeneste med gode eksklusive podcasts og derudover et kæmpe udvalg af podcasts og lydbøger. Kan varmt anbefales, om ikke andet så udelukkende pga Dårligdommerne, Klovn podcast, Hakkedrengene og Han duo 😁 👍
Podimo er blevet uundværlig! Til lange bilture, hverdagen, rengøringen og i det hele taget, når man trænger til lidt adspredelse.

Choose your subscription

Most popular

Limited Offer

Premium

20 hours of audiobooks

  • Podcasts only on Podimo

  • No ads in Podimo shows

  • Cancel anytime

2 months for 19 kr.
Then 99 kr. / month

Get Started

Premium Plus

Unlimited audiobooks

  • Podcasts only on Podimo

  • No ads in Podimo shows

  • Cancel anytime

Start 7 days free trial
Then 129 kr. / month

Start for free

Only on Podimo

Popular audiobooks

Get Started

2 months for 19 kr. Then 99 kr. / month. Cancel anytime.